pemetrexed – Page 2 – Medical News Asia

Tag Archive for: pemetrexed

Making sense of 1st-line immunotherapy in non-small cell lung cancer (NSCLC)

26 March 2018/5 Comments/in Lung Cancer, Oncology, Immunotherapy, Guidelines/by Stijn van den Borne, MSc

The expansion of therapeutic options with immunotherapies will reflect a dramatic change in the guidelines for lung cancer, where immunotherapies mostly compete with the use of chemotherapeutic agents. A brief communication on immunotherapies for NSCLC.

FDA approved durvalumab as maintenace for unresectable stage III NSCLC responding to platinum-based chemoradiation therapy

16 February 2018/0 Comments/in US FDA Onc\Haem Approvals, Uncategorised/by scienterrific

FDA approved durvalumab (Imfinzi, AstraZeneca Inc.) for patients with unresectable stage III non-small cell lung cancer (NSCLC) whose disease has not progressed following concurrent platinum-based chemotherapy and radiation therapy. More Information.